GlaxoSmithKline Pharmaceuticals Limited

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

india-pharma.gsk.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-03

Stock price
₹2937.50
Market cap
49,765 Cr
Stock P/E
45.0
P/B
21.78
Dividend yield
1.4%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales957 Cr805 Cr930 Cr815 Cr1,011 Cr949 Cr974 Cr805 Cr980 Cr1,041 Cr995 Cr938 Cr
Operating expenses (approx.)668 Cr587 Cr673 Cr584 Cr689 Cr658 Cr641 Cr554 Cr644 Cr670 Cr644 Cr643 Cr
EBITDA289 Cr218 Cr257 Cr231 Cr322 Cr292 Cr333 Cr251 Cr336 Cr371 Cr351 Cr296 Cr
OPM %30.3%27.1%27.7%28.3%31.8%30.7%34.2%31.2%34.3%35.7%35.3%31.5%
Other income28 Cr28 Cr30 Cr36 Cr35 Cr35 Cr41 Cr44 Cr34 Cr32 Cr36 Cr44 Cr
Interest0.43 Cr0.32 Cr0.77 Cr0.37 Cr0.27 Cr0.09 Cr0.58 Cr0.42 Cr0.51 Cr1 Cr0.61 Cr0.97 Cr
Depreciation18 Cr17 Cr18 Cr16 Cr17 Cr19 Cr15 Cr16 Cr17 Cr20 Cr13 Cr16 Cr
Profit before tax299 Cr65 Cr271 Cr249 Cr344 Cr308 Cr359 Cr279 Cr354 Cr400 Cr373 Cr322 Cr
Tax %27.3%30.1%28.1%26.9%26.6%25.4%26.7%26.5%27.3%26.1%25.5%26.4%
Net profit218 Cr46 Cr194 Cr182 Cr253 Cr230 Cr263 Cr205 Cr257 Cr296 Cr278 Cr237 Cr
EPS (₹)₹12.84₹9.89₹11.48₹10.76₹14.67₹13.57₹15.52₹12.10₹15.07₹16.54₹16.40₹14.00

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales3,128 Cr3,224 Cr3,199 Cr3,278 Cr3,252 Cr3,454 Cr3,749 Cr3,822 CrSign in for TTM
Operating expenses (approx.)2,527 Cr2,567 Cr2,504 Cr2,516 Cr2,447 Cr2,545 Cr2,572 Cr2,512 CrSign in for TTM
EBITDA601 Cr657 Cr695 Cr762 Cr804 Cr909 Cr1,177 Cr1,309 CrSign in for TTM
OPM %19.2%20.4%21.7%23.2%24.7%26.3%31.4%34.3%Sign in for TTM
Other income102 Cr79 Cr111 Cr76 Cr101 Cr123 Cr146 Cr145 CrSign in for TTM
Interest0.55 Cr6 Cr4 Cr2 Cr2 Cr2 Cr1 Cr3 CrSign in for TTM
Depreciation49 Cr83 Cr79 Cr68 Cr66 Cr70 Cr67 Cr66 CrSign in for TTM
Profit before tax683 Cr306 Cr551 Cr2,487 Cr841 Cr816 Cr1,260 Cr1,406 CrSign in for TTM
Tax %34.8%69.5%34.9%16.0%27.2%27.7%26.4%26.3%Sign in for TTM
Net profit445 Cr93 Cr358 Cr1,695 Cr611 Cr590 Cr928 Cr1,036 CrSign in for TTM
EPS (₹)₹26.29₹5.50₹21.14₹100.04₹36.05₹34.83₹54.52₹54.52Sign in for TTM
Dividend payout %———29.9%249.8%91.8%80.8%68.9%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital169 Cr169 Cr169 Cr169 Cr169 Cr169 Cr169 Cr169 Cr
Reserves1,970 Cr1,651 Cr1,330 Cr2,494 Cr1,572 Cr1,608 Cr1,782 Cr2,098 Cr
Borrowings0.18 Cr0.02 Cr——————
Other liabilities1,771 Cr1,315 Cr1,614 Cr1,970 Cr1,585 Cr1,779 Cr2,157 Cr2,039 Cr
Total liabilities3,911 Cr3,136 Cr3,113 Cr4,633 Cr3,327 Cr3,557 Cr4,108 Cr4,324 Cr
Fixed assets (net)364 Cr707 Cr341 Cr295 Cr295 Cr297 Cr270 Cr274 Cr
CWIP1,003 Cr120 Cr13 Cr31 Cr20 Cr14 Cr14 Cr33 Cr
Investments2 Cr1 Cr1 Cr367 Cr519 Cr814 Cr1,119 Cr1,392 Cr
Inventories486 Cr483 Cr547 Cr535 Cr460 Cr525 Cr482 Cr458 Cr
Trade receivables120 Cr100 Cr216 Cr205 Cr192 Cr222 Cr293 Cr273 Cr
Cash & bank99 Cr105 Cr405 Cr286 Cr35 Cr64 Cr539 Cr1,102 Cr
Other assets1,837 Cr1,619 Cr1,590 Cr2,915 Cr1,805 Cr1,620 Cr1,392 Cr792 Cr
Total assets3,911 Cr3,136 Cr3,113 Cr4,633 Cr3,327 Cr3,557 Cr4,108 Cr4,324 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———811 Cr484 Cr582 Cr1,290 Cr903 Cr
Cash from investing———-405 Cr808 Cr9 Cr-46 Cr397 Cr
Cash from financing———-524 Cr-1,543 Cr-561 Cr-769 Cr-737 Cr
Net cash flow———-119 Cr-251 Cr29 Cr475 Cr563 Cr
Free cash flow (OCF − Capex)———776 Cr440 Cr551 Cr1,267 Cr848 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %31.9%17.1%37.0%93.5%48.4%46.0%64.6%61.7%
ROE %20.6%5.1%23.9%130.8%35.1%33.2%0.0%45.3%
Debtor days1411252322232826
Inventory days258372422318392352351382
Days payable215275358340364419516476
Cash conversion cycle5710888149-44-137-68
Debt / equity0.000.00000.000.000.000.00—0.00
Current ratio1.382.041.782.302.041.981.892.13
Net debt / EBITDA0.000.000.000.00-0.04-0.07-0.46-0.84

Compare with peers

Loading peers…